Shifting the paradigm for maintenance therapy in advanced non-small-cell lung cancer
{{output}}
The standard of care in metastatic non-small-cell lung cancer (NSCLC) is to treat patients with a platinum doublet for 4 to 6 cycles and to offer second-line therapy upon progression. Maintenance therapy in NSCLC is defined as a therapeutic agent which is admi... ...
